LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.4050
-0.0150 (-3.57%)
At close: May 12, 2026
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 73.62 million as of May 12, 2026. Its market cap has increased by 4.31% in one year.
Market Cap
73.62M
Enterprise Value
47.84M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.41
Market Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 73.62M, an increase of 38.96%. That is a compound annual growth rate of 14.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 76.35M | -41.62% |
| Dec 31, 2025 | 130.78M | -10.78% |
| Dec 31, 2024 | 146.59M | 204.77% |
| Dec 29, 2023 | 48.10M | -9.21% |
| Dec 11, 2023 | 52.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 104.31M |
| Paradigm Biopharmaceuticals | 97.21M |
| Arovella Therapeutics | 91.87M |
| Immutep | 88.42M |
| Cynata Therapeutics | 79.55M |
| Botanix Pharmaceuticals | 73.45M |
| Radiopharm Theranostics | 67.34M |
| Amplia Therapeutics | 66.70M |